McKesson Renews Distribution Contract with VA

McKesson Corp.’s deal to be the primary pharmaceutical supplier for the Department of Veterans Affairs has been renewed for the next two years. The Irving-based pharmaceutical distribution company will continue their partnership with the nation’s largest integrated healthcare system. McKesson will supply all the VA medical centers and clinics as well as their outpatient pharmacies, which include 750 locations and 270 medical centers. The distributor is the largest non-defense vendor serving the VA, Department of Defense, and other government branches. “McKesson has had the privilege of supporting the VA as their prime pharmaceutical supplier since 2004,” said Brian Tyler, McKesson’s… Full Story

McKesson and Walgreens Boots Alliance Form Joint Venture

Retail pharmacy giants Walgreens Boots Alliance is forming a joint venture with Irving-based McKesson Corp. to combine their pharmaceutical wholesale businesses in Germany. WBA will control 70 percent of the venture and McKesson the remaining 30. The combination is limited to the German wholesale activity of the two companies and won’t impact any other operations. “Combining our wholesale operations is the right decision to secure the long-term success of both businesses,” said Ornella Barra, Co-Chief Operating Officer of WBA via release. “This is a strategic step that will offer benefits for all. We are creating a sustainable company to drive success… Full Story

Expert: The Risks and Rewards of Medical Tourism

Each year, thousands of Americans travel abroad to seek medical care elsewhere. Their motivations vary, but oftentimes, this is motivated by finances. Certain pharmaceutical agents, as well as surgical procedures, can be less costly overseas. However, this portends risks about which the individual may not necessarily be aware. Some patients seek aesthetic surgery in the Caribbean, Mexico, or Central America because it is cheaper than compared to undergoing the procedure by a qualified, trained plastic surgeon in the U.S. While there are many well-trained surgeons in these nations, it may be hard for the average consumer to appropriately evaluate if… Full Story

McKesson Names New EVP, CIO, and CTO

Nancy Flores will be McKesson’s new executive vice president, chief information officer and chief technology officer beginning Jan. 13, 2020. She is currently the CIO for Johnson Controls, a multinational company that makes fire, HVAC, and building security equipment now based in Ireland. Flores will succeed Kathy McElligott, who announced her retirement earlier this year. Flores will be responsible for the enterprise business technology strategy and technology governance for the corporation. She will also lead the development and application of healthcare technology products at the company. Prior to her time at Johnson Controls, Flores was vice president for business and technology… Full Story

Plano-Based Reata Pharmaceuticals Raises $500 Million in Stock Offering

Plano-based Reata Pharmaceuticals, a clinical-stage biopharmaceutical company, raised $505.1 million via a stock offering that sold 2,760,000 shares of Class A common stock ahead of commercializing its existing clinical-stage treatments. The stock sales will add to the company’s working capital supply and corporate funds, which they intend to use to develop new drugs that fight Alport syndrome, which is a genetic condition that causes by kidney disease , hearing loss, and eye problems, and Friederich’s ataxia, a neurological disorder that causes falling, and difficulty in because of  issues with the ability to coordinate voluntary movements and causes death in the patient’s 30s.… Full Story

Parkland’s Lawsuit: Are Drug Distributors to Blame for the Opioid Epidemic?

Earlier this year, dozens of health systems in Texas filed a civil lawsuit against opioid manufacturers, distributors, and retailers. Two local entities, Parkland Hospital and Health System and McKesson Corp., are on opposite sides of the lawsuit. But why are the health systems taking legal action, and should distributors be held accountable for what physicians are prescribing? In 2010, opioid prescriptions peaked when providers wrote 81.2 prescriptions per 100 persons. In 2017, around 57 million people had at least one prescription for opioids, with 191 opioid prescriptions dispensed, according to CDC data. Darren Nicholson, of Burns Charest LLP in Dallas,… Full Story

Texas Health Protocol Has Cut Opioid Use by 70 Percent

Physicians at Texas Health Harris Methodist Hospital Southwest Fort Worth are using a protocol that reduces the use of opioids after a C-section called Enhanced Recovery After Surgery. Normally, a small amount of fentanyl is used in the surgery, and opioids are prescribed every three hours after the surgery, but the new protocol uses a long lasting medication called liposomal bupivacaine, which is injected into the incision and paired with oral acetaminophen and ibuprofen. The protocol allows the physicians to stay ahead of the pain and not need opioids. Though patients still have the option of taking opioids, hospital staff says… Full Story

Gift of Life Honors McKesson as Corporate Partner

McKesson Corp. was presented with the Corporate Partner Award from the Gift of Life Marrow Registry for its work facilitating bone marrow and stem cell transplants for leukemia and other blood cancer patients. Irving-based McKesson gives its employees opportunities to join the registry with a simple cheek swab throughout the year, and opens the drive to employees’ families and friends as well. Six life-saving transplants have resulted from the company’s matches. The Gift of Life Marrow Registry includes 354,000 individuals who have volunteered to donate blood stem cells or bone marrow since its inception in 1991. The group has coordinated… Full Story

Collin Allred’s Bipartisan Bill to Reduce Insulin Prices

North Texas Democratic Congressman Colin Allred is cosponsoring the Insulin Price Reduction Act, a bipartisan measure to bring down the price of insulin for millions. Additional sponsors are Colorado Democrat Diane Degette and New York Republican Tom Reed. The new bill would reduce the price of most insulin products by more than 75 percent, and gives drugmakers an incentive to keep insulin prices set at 2006 levels. It would require Medicare and private insurers to waive deductible requirements for insulin set at 2006 prices, and would give protection to drug makers who comply by allowing them to not make any… Full Story

McKesson and Aetion Partner Up for Real World Cancer Insights

McKesson and healthcare technology company Aetion have announced a collaboration to advance cancer research. The partnership is meant to advance the use of real-world evidence to aid the cancer infrastructure and help fight multiple tumor types. The Aetion Evidence Platform will work with McKesson’s iKnowMed oncology electronic health record to improve research for an FDA project at Brigham and Women’s Hospital. The solution will improve insight, safety, and allow companies to assess the economic impact of treatments. Aetion analyzes health data from the real world to provide answers about treatments, costs, and outcomes for providers, payers, and regulatory agencies. “This collaboration… Full Story